Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines

By Pluim Dick   Waardenburg Robert   Beijnen Jos   Schellens Jan  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 1, 2004-07 ,pp. : 71-78

Springer Publishing Company

Access to resources Recommend Favorite

Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells

By Bacac Marina   Vadori Marta   Sava Gianni   Pacor Sabrina  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 12, 2004-12 ,pp. : 1101-1110

Springer Publishing Company

Access to resources Recommend Favorite

CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 8, 2012-10 ,pp. : 949-958

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Chemical Inhibitors and Ionizing Radiation on Arvin Activity

By Beamont K.P.   Phillips G.O.   Power D.M.  

International Journal of Radiation Biology, Vol. 22, Iss. 2, 1972-08 ,pp. : 137-148

Informa Healthcare

Access to resources Recommend Favorite

Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 2, 2017-01 ,pp. : 212-220

Bentham Science Publishers

Access to resources Recommend Favorite